Any current/future new fundraising through debt or equity?

Kaya Limited is planning a rights issue for fundraising, with a substantial amount of around Rs. 300 Crores mentioned. The exact timing and details of the rights issue are not disclosed yet as the company is still working on submissions and approvals. The rights issue committee is already in place and once filed with authorities, information will be made public. The raised funds are expected partly to be used for debt reduction and expansion in India and overseas, but precise plans are not finalized. No clear guidance on future debt raising or other equity fundraisings beyond the rights issue

Any current/future capex/capital investment/strategic investment?

Capex per clinic is approximately Rs. 1.5 Crore, including machines. (Page 9) Expansion focused on Tier-2 cities and peripheral regions with opportunistic clinic openings where rental costs are favorable (e.g., Lucknow, Surat, Siliguri, Electronic City Bangalore). (Pages 5, 9, 12) Rights issue fundraising planned (~Rs. 300 Crores) with utilization details and timing currently not disclosed; intended partly for expansion and possibly debt reduction. (Pages 6-7) No immediate plans to set up peripheral businesses like laboratory sample collection; collaborations and tie-ups are preferred for diag

Future growth expectations in sales/revenue/volumes?

Kaya India clinics achieved strong 20% growth in Q2 FY2024 versus last year. New growth levers (body category, nutraceuticals, innovation, omni-channel, new clinics) contributed 63% of growth. Clinic net revenue grew 21%, product business grew 34% (notably skin and nutraceuticals). Renewed focus on hair care category drove 24% growth. Expansion into Tier-2 cities and peripheral regions is underway (e.g., Surat, Lucknow, Siliguri, Electronic City Bangalore). Clinic business growing at about 18% for centers operational over two years. Capacity utilization in clinics is being increased from curre

Future growth expectations in earnings/operating earnings/profits/EPS?

The company currently does not provide explicit forward-looking guidance on EBITDA or profits but emphasizes aiming for sustainable EBITDA levels to drive profitability (Page 14, Saurabh Shah). Clinic EBITDA is around 27%, with corporate level EBITDA at approximately 2%, indicating potential room for margin improvement (Page 14). Growth levers include expansion into new segments like hair care and nutraceuticals, which have shown strong contributions recently (Page 14). The D2C business is being promoted strongly, integrating with clinics for faster delivery, potentially increasing product rev

Kaya LtdQ2 FY24Leisure Services

Kaya Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹312.4Market Cap: ₹474 CrSector: Leisure Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Kaya India clinics achieved strong 20% growth in Q2 FY2024 versus last year.
New growth levers (body category, nutraceuticals, innovation, omni-channel, new clinics) contributed 63% of growth.
Clinic net revenue grew 21%, product business grew 34% (notably skin and nutraceuticals).
Renewed focus on hair care category drove 24% growth.
Expansion into Tier-2 cities and peripheral regions is underway (e.g., Surat, Lucknow, Siliguri, Electronic City Bangalore).
Clinic business growing at about 18% for centers operational over two years.
Capacity utilization in clinics is being increased from current ~55-70%.
D2C business growing, with improved integration between clinics and online sales.
Middle East business (especially UAE) showing growth; UAE clinic EBITDA ~30%.
Management cautious with forward-looking guidance but aims for sustainable EBITDA growth and expansion driven by new clinics and categories.

Margin guidance

Category 3

The company currently does not provide explicit forward-looking guidance on EBITDA or profits but emphasizes aiming for sustainable EBITDA levels to drive profitability (Page 14, Saurabh Shah).
Clinic EBITDA is around 27%, with corporate level EBITDA at approximately 2%, indicating potential room for margin improvement (Page 14).
Growth levers include expansion into new segments like hair care and nutraceuticals, which have shown strong contributions recently (Page 14).
The D2C business is being promoted strongly, integrating with clinics for faster delivery, potentially increasing product revenue share over time (Page 14).
Clinic expansion focused on Tier-2 and peripheral regions with better profitability potential is ongoing (Page 9 and 12).
Utilization improvements (currently ~55-70%) through better machine deployment aim to increase revenue per clinic (Page 6).
Rights issue proceeds (Rs. 300 Crores) are expected to support expansion and debt reduction, but detailed utilization timelines are pending (Page 7).

See what Kaya Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Kaya Limited is planning a rights issue for fundraising, with a substantial amount of around Rs. 300 Crores mentioned.
The exact timing and details of the rights issue are not disclosed yet as the company is still working on submissions and approvals.
The rights issue committee is already in place and once filed with authorities, information will be made public.
The raised funds are expected partly to be used for debt reduction and expansion in India and overseas, but precise plans are not finalized.
No clear guidance on future debt raising or other equity fundraisings beyond the rights issue was provided.
The company is cautious on commenting further until formal processes complete.

Order book

The provided transcript and document pages do not contain any specific information regarding Kaya Limited's current or expected order book or pending orders. The discussion mostly focuses on operational performance, clinic growth, unit economics, customer journey, regional market performance, capital expenditure per clinic, and rights issue fundraising. There is no mention or data shared about order books or pending orders.

See what Kaya Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Capex per clinic is approximately Rs. 1.5 Crore, including machines. (Page 9)
Expansion focused on Tier-2 cities and peripheral regions with opportunistic clinic openings where rental costs are favorable (e.g., Lucknow, Surat, Siliguri, Electronic City Bangalore). (Pages 5, 9, 12)
Rights issue fundraising planned (~Rs. 300 Crores) with utilization details and timing currently not disclosed; intended partly for expansion and possibly debt reduction. (Pages 6-7)
No immediate plans to set up peripheral businesses like laboratory sample collection; collaborations and tie-ups are preferred for diagnostics and related services. (Page 5)
D2C (Direct-to-Consumer) business platform launched and integrated with clinics to supply products within a day, indicating investment in digital capabilities. (Page 14)
No forward-looking specific capex or strategic investment guidance provided currently. (Pages 14-15)

Track Kaya Ltd — get its next earnings analysis in your feed

How does Kaya Ltd rank vs peers in Leisure Services?

Pro feature

ThisKaya Ltd

Rev 3Mar 3

See where Kaya Ltd sits in Leisure ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Kaya Ltd rank in Leisure Services?

Compare Kaya Ltd against every Leisure Services company (Q2 FY24) on revenue, margins and earnings-call signals.

View Leisure Services leaderboard →

What Kaya Ltd's management said in earlier quarters

Others in Leisure Services this season

Delta Corp (Q2 FY27)
For the quarter ended 30th September 2026, consolidated net sales/revenue from operations was ₹159.34 crores, down from ₹182.76 crores in the same quarter last…
Le Travenues Technology Ltd (Q2 FY27)
Gross Transaction Value (GTV): ₹5,304.47 crores, up 22% YoY . Key investor presentation takeaways from Le Travenues Technology Ltd's Q2 FY27 investor presentati
Ventive Hospitality Ltd (Q2 FY26)
Direct booking channels growing, especially in India (currently 60% of sales) and Maldives, enhancing margins and revenues. Key concall takeaways from Ventive…
Imagicaaworld Entertainment Ltd (Q2 FY26)
41.8 Cr, up 4.6% from Rs. Key investor presentation takeaways from Imagicaaworld Entertainment Ltd's Q2 FY26 investor presentation — and how it ranks against se

Compare:vs Indian Hotels Co Ltd vs Indian Railway Catering & Tourism Corporation Ltd vs ITC Hotels

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Kaya Ltd Q2 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Kaya Ltd rank in Leisure Services?

Continue your research

What Kaya Ltd's management said in earlier quarters

Others in Leisure Services this season